Alice C. Brennan, a director at Horizon Kinetics Holding Corp (), purchased common stock valued at $5,240 on August 28, 2026. Brennan acquired 200 shares of Horizon Kinetics Holding Corp common stock at a price of $26.2 per share. Following this
DST Global Advisors Ltd., a significant shareholder and director of Chime Financial, Inc. (), reported the sale of 1,168,667 shares of Class A Common Stock on August 26, 2026. The transactions, totaling approximately $38.6 million, occurred at prices ranging from $33.00
Scott McLean Hanson, Chief Technology Officer and a Director at Ambiq Micro, Inc. (), recently sold company shares totaling over $3.28 million, according to a regulatory filing dated August 28, 2026. These transactions occurred on August 26 and 27, 2026, and involved
Jeffrey B. Kindler, a director at Precigen, Inc. (), sold 185,000 shares of the company’s common stock on August 26, 2026. The series of transactions amounted to a total value of $1,376,400. The shares were sold at prices ranging
Joseph M Palumbo, Chief Medical Officer at BIOVIE INC. (), recently increased his holdings in the company through open market purchases. According to a Form 4 filing with the Securities and Exchange Commission, Mr. Palumbo acquired 4,843 shares
Anastasios Psaropoulos, Chief Financial Officer of Global Ship Lease, Inc. (), recently sold Class A common shares totaling approximately $2.25 million. The transactions occurred over two days, with shares sold at prices ranging from $45.0246 to $45.03. The sale
Frank Klein, Chief Operations Officer at Rocket Lab Corp (), sold common stock totaling $2,368,353 on August 27, 2026. The transactions were executed at weighted-average prices ranging from $66.251 to $67.5387 per share. Mr. Klein disposed of a total of 35,558 shares
William D. Rogers, a Director at BATTALION OIL CORP (), recently acquired 70,000 shares of the company’s common stock for a total value of $91,168. The transactions occurred on August 26, 2026. The shares were purchased at a weighted
James A Beer, a director at DocuSign, Inc. (), sold shares of the company’s common stock totaling $28,809 on August 28, 2026. The shares were sold at a price of $64.02 each. The transaction involved the disposition of 450 shares.
Fidelity & Guaranty Life Insurance Co., a 10% owner and director of Crescent Capital BDC, Inc. (), recently sold shares totaling $628,590. The transactions occurred over two days, August 26 and August 27, 2026, with the volume-weighted average prices for the sales
